Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Journey Medical (DERM) Gross Profit (2020 - 2025)

Journey Medical (DERM) has disclosed Gross Profit for 5 consecutive years, with $11.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Gross Profit rose 10.95% year-over-year to $11.3 million, compared with a TTM value of $38.6 million through Sep 2025, up 95.05%, and an annual FY2024 reading of $35.3 million, down 4.12% over the prior year.
  • Gross Profit was $11.3 million for Q3 2025 at Journey Medical, up from $10.1 million in the prior quarter.
  • Across five years, Gross Profit topped out at $28.1 million in Q3 2023 and bottomed at -$6.5 million in Q4 2023.
  • Average Gross Profit over 5 years is $9.2 million, with a median of $8.9 million recorded in 2022.
  • The sharpest move saw Gross Profit tumbled 179.36% in 2023, then soared 237.33% in 2024.
  • Year by year, Gross Profit stood at $8.0 million in 2021, then grew by 2.64% to $8.2 million in 2022, then crashed by 179.36% to -$6.5 million in 2023, then skyrocketed by 237.33% to $8.9 million in 2024, then increased by 26.06% to $11.3 million in 2025.
  • Business Quant data shows Gross Profit for DERM at $11.3 million in Q3 2025, $10.1 million in Q2 2025, and $8.3 million in Q1 2025.